A reduced-intensity induction regimen for acute myeloid leukaemia (AML) in paediatric patients with Down's syndrome has been evaluated

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1618, 2007-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In elderly patients with poor-prognosis acute myeloid leukaemia (AML), filgrastim may be a beneficial adjunct to supportive care

By  

Inpharma, Vol. 1, Iss. 1576, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor (G-CSF) does not appear to have any additional benefit in patients with acute myeloid leukaemia (AML) receiving chemotherapy

By  

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Flexible low-intensity combination chemotherapy is comparable to more aggressive regimens in elderly patients with acute myeloid leukaemia

By  

Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Flexible Low-Intensity Combination Chemotherapy for Elderly Patients with Acute Myeloid Leukaemia: A Multicentre, Phase II Study

By Manoharan Arumugam  

Drugs & Aging, Vol. 24, Iss. 6, 2007-01 ,pp. : 481-488

Adis International

Access to resources Recommend Favorite

Mitoxantrone: Acute myeloid leukaemia: 2 patients

By  

Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite